JP Morgan Chase’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

JP Morgan Chase’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-60,000	Closed	-$10.1M	–	6119
2019 Q1	$10.1M	Buy	+60,000	New	+$8.93M	﹤0.01%	2037
2018 Q4	–	Sell	-30,000	Closed	-$5.18M	–	6037
2018 Q3	$5.18M	Buy	+30,000	New	+$4.33M	﹤0.01%	2719
2016 Q2	–	Sell	-25,000	Closed	-$1.8M	–	5061
2016 Q1	$1.8M	Buy	+25,000	New	+$1.37M	﹤0.01%	2754

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

JP Morgan Chase's GWPH Position: Q2 2021 in Review

JP Morgan Chase sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 385,738 shares — an estimated $83.7M sold.

JP Morgan Chase first reported a position in GWPH in Q4 2014 and held it in 26 quarters. The position peaked at $83.7M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

JP Morgan Chase reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
JP Morgan Chase sold 385,738 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $83.7M.
JP Morgan Chase first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2014 and held it in 26 quarters.
JP Morgan Chase's GW Pharmaceuticals Plc American Depositary Shares position peaked at $83.7M in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on JP Morgan Chase's 13F filing for Q2 2021, filed 12 Aug 2021.